DMAA

Financials

Drugs Made In America Acquisition Corp

$10.60+0.02 (+0.19%)PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving DMAA Today?

No stock-specific AI insight has been generated for DMAA yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$357M

P/E Ratio—

EPS—

Dividend Yield—

Dividend / Share—

ROE—

Profit Margin—

Debt / Equity—

Trading

Volume14K

Avg Volume (10D)—

Shares Outstanding33.7M

DMAA News

1 article

Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) is definitely on the radar of institutional investors who own 38% of the companyYahoo Finance·Aug 16, 2025

All 1 articles loaded

Price Data

Open$0.00

Previous Close$10.58

Day High$0.00

Day Low$0.00

52 Week High—

52 Week Low—

Fundamentals

Market Cap$357M

P/E Ratio—

EPS—

Dividend Yield—

Dividend / Share—

ROE—

Profit Margin—

Debt / Equity—

Trading

Volume14K

Avg Volume (10D)—

Shares Outstanding33.7M

About Drugs Made In America Acquisition Corp

Drugs Made In America Acquisition Corp is a blank check company.

Listed February 25, 2025

FinancialsBLANK CHECKS

Company Details

Security TypeStock

ExchangeNASDAQ

Currency—

Round Lot—

SICBLANK CHECKS

CIK—

Composite FIGI—

Share Class FIGI—